-
InsightsHow Pharma Teams Can Identify KOLs Through Scientific Publications (at Scale)
Isabel Wellbery • -
InsightsReaching the Unreached HCPs: From Engagement to Activation Mindset
Isabel Wellbery • -
InsightsRethinking KOL Strategy in 2025: Why Influence Looks Different Post-Pandemic
James Dalton • -
InsightsThe Complete Q&A Guide to Physician Engagement and Activation in Life Sciences
Isabel Wellbery • -
InsightsUsing Healthcare Data to Build Better Advisory Boards
Isabel Wellbery • -
InsightsPersonalizing HCP Outreach at Scale: A Guide for Pharma and MedTech Teams
Isabel Wellbery • -
InsightsA Day in the Life of a Medical Science Liaison (MSL) in the Pharma Industry
Isabel Wellbery • -
InsightsHow MSLs at Small Pharma Companies Can Be More Effective Using Alpha Sophia
Isabel Wellbery • -
InsightsHow Medical Affairs Can Build Smarter Medical Advisory Boards
Isabel Wellbery •